James E. Hilbert

1.7k citations

29 papers · 1.1k indexed · h-index 20

Impact in

Cellular and Molecular Neuroscience top 2%
- Genetic Neurodegenerative Diseases
- Neuropeptides and Animal Physiology
Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Cellular and Molecular Neuroscience 22
- Genetic Neurodegenerative Diseases 20
- Hereditary Neurological Disorders 2
- Neuropeptides and Animal Physiology 2
Neurology 15
- Parkinson's Disease Mechanisms and Treatments 12
- Botulinum Toxin and Related Neurological Disorders 3

Co-authors: Richard T. Moxley (19 shared papers)Gary A. Sforzo (2 shared papers)T. Swensen (2 shared papers)Charles A. Thornton (13 shared papers)William B. Martens (14 shared papers)Elizabeth Luebbe (12 shared papers)Michael McDermott (10 shared papers)Mark H. Greene (6 shared papers)
Journals: Neurology (4 papers)Muscle & Nerve (4 papers)Journal of Neurology (3 papers)Journal of Medicinal Chemistry (3 papers)JAMA (1 paper)
Partner nations: United States Sweden Germany

In The Last Decade

James E. Hilbert

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by James E. Hilbert

Since Specialization

Citations

This map shows the geographic impact of James E. Hilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Hilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Hilbert more than expected).

Fields of papers citing papers by James E. Hilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Hilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Hilbert. The network helps show where James E. Hilbert may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Hilbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Hilbert Line = papers co-authored together James E. Hilbert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The effects of massage on delayed onset muscle soreness British Journal of Sports Medicine ·James E. Hilbert, Gary A. Sforzo, T. Swensen	2003	148
2	Cancer Risk Among Patients With Myotonic Muscular Dystrophy JAMA ·Shahinaz M. Gadalla, Marie Lund, Ruth M. Pfeiffer, Sanne Gørtz, Christine M. Mueller, Richard T. Moxley, Sigurður Y. Kristinsson, Magnus Björkholm, Fatma M. Shebl, James E. Hilbert, Ola Landgren, Jan Wohlfahrt, Mads Melbye, Mark H. Greene	2011	89
3	Diagnostic odyssey of patients with myotonic dystrophy Journal of Neurology ·James E. Hilbert, Tetsuo Ashizawa, John Day, Elizabeth Luebbe, William B. Martens, Michael McDermott, Rabi Tawil, Charles A. Thornton, Richard T. Moxley	2013	72
4	Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors Journal of Medicinal Chemistry ·John L. Neumeyer, Ao Zhang, Wennan Xiong, Xiao‐Hui Gu, James E. Hilbert, Brian I. Knapp, S. Stevens Negus, Nancy K. Mello, Jean M. Bidlack	2003	71
5	Hypothesis: neoplasms in myotonic dystrophy Cancer Causes & Control ·Christine M. Mueller, James E. Hilbert, William B. Martens, Charles A. Thornton, Richard T. Moxley, Mark H. Greene	2009	49
6	If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD) Contemporary Clinical Trials ·James E. Hilbert, John T. Kissel, Elizabeth Luebbe, William B. Martens, Michael McDermott, Donald B. Sanders, Rabi Tawil, Charles A. Thornton, Richard T. Moxley	2011	49
7	The hypocretin neurotransmission system in myotonic dystrophy type 1 Neurology ·Emma Ciafaloni, Emmanuel Mignot, Valeria Sansone, James E. Hilbert, Leo L. Lin, X. Lin, L. C. Liu, Wilfred R. Pigeon, Michael L. Perlis, Charles A. Thornton	2008	48
8	2-Aminothiazole-Derived Opioids. Bioisosteric Replacement of Phenols Journal of Medicinal Chemistry ·Ao Zhang, Wennan Xiong, James E. Hilbert, Emily K. DeVita, Jean M. Bidlack, John L. Neumeyer	2004	47
9	Myotonic Dystrophy Health Index: Initial evaluation of a disease‐specific outcome measure Muscle & Nerve ·Chad Heatwole, Rita Bode, Nicholas E. Johnson, Jeanne Dekdebrun, Nuran Dilek, Mark Heatwole, James E. Hilbert, Elizabeth Luebbe, William B. Martens, Michael McDermott, Nan Rothrock, Charles A. Thornton, Barbara G. Vickrey, David Victorson, Richard T. Moxley	2013	47
10	Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2) Neurology ·Chad Heatwole, Nicholas E. Johnson, Rita Bode, Jeanne Dekdebrun, Nuran Dilek, James E. Hilbert, Elizabeth Luebbe, William B. Martens, Michael McDermott, Christine Quinn, Nan Rothrock, Charles A. Thornton, Barbara G. Vickrey, David Victorson, Richard T. Moxley	2015	45
11	Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1 Archives of Neurology ·Chad Heatwole, Katy Eichinger, Deborah I. Friedman, James E. Hilbert, Carlayne E. Jackson, Eric L. Logigian, William B. Martens, Michael McDermott, Shree K. Pandya, Christine Quinn, Alexis M. Smirnow, Charles A. Thornton, Richard T. Moxley	2010	40
12	Parent‐reported multi‐national study of the impact of congenital and childhood onset myotonic dystrophy Developmental Medicine & Child Neurology ·Nicholas E. Johnson, Anne‐Berit Ekström, Craig Campbell, Man Hung, Heather Adams, Wei Chen, Elizabeth Luebbe, James E. Hilbert, Richard T. Moxley, Chad Heatwole	2015	38
13	High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2 Neurology ·James E. Hilbert, Richard J. Barohn, Paula R. Clemens, Elizabeth Luebbe, William B. Martens, Michael McDermott, Amy L. Parkhill, Rabi Tawil, Charles A. Thornton, Richard T. Moxley, Tetsuo Ashizawa, P. Michael Conneally, John Day, Denise A. Figlewicz, Jacqueline M. Jackson, John T. Kissel, Shannon Lord, Katherine D. Mathews, Donald B. Sanders, Stephen J. Tapscott	2017	37
14	10-Ketomorphinan and 3-Substituted-3-desoxymorphinan Analogues as Mixed κ and μ Opioid Ligands: Synthesis and Biological Evaluation of Their Binding Affinity at Opioid Receptors Journal of Medicinal Chemistry ·Ao Zhang, Wennan Xiong, Jean M. Bidlack, James E. Hilbert, Brian I. Knapp, Mark P. Wentland, John L. Neumeyer	2003	37
15	Mexiletine in Myotonic Dystrophy Type 1 Neurology ·Chad Heatwole, Elizabeth Luebbe, Spencer Rosero, Katy Eichinger, William B. Martens, James E. Hilbert, Jeanne Dekdebrun, Nuran Dilek, Christine Zizzi, Nicholas E. Johnson, Araya Puwanant, Rabi Tawil, Giovanni Schifitto, Christopher A. Beck, J. Franklin Richeson, Wojciech Zaręba, Charles A. Thornton, Michael McDermott, Richard T. Moxley	2020	37
16	Correlates of tumor development in patients with myotonic dystrophy Journal of Neurology ·Maya Das, Richard T. Moxley, James E. Hilbert, William B. Martens, Lisa Letren, Mark H. Greene, Shahinaz M. Gadalla	2012	36
17	Consensus-based care recommendations for adults with myotonic dystrophy type 2 Neurology Clinical Practice ·Benedikt Schoser, Federica Montagnese, Guillaume Bassez, Barbara Fossati, Josep Gámez, Chad Heatwole, James E. Hilbert, Cornelia Kornblum, Anna Kostera‐Pruszczyk, Ralf Krahe, Anna Łusakowska, G. Meola, Richard T. Moxley, Charles A. Thornton, Bjarne Udd, Paul Formaker	2019	35
18	Myotonic dystrophy health index: Correlations with clinical tests and patient function Muscle & Nerve ·Chad Heatwole, Rita Bode, Nicholas E. Johnson, Jeanne Dekdebrun, Nuran Dilek, Katy Eichinger, James E. Hilbert, Eric L. Logigian, Elizabeth Luebbe, William B. Martens, Michael McDermott, Shree Pandya, Araya Puwanant, Nan Rothrock, Charles A. Thornton, Barbara G. Vickrey, David Victorson, Richard T. Moxley	2015	33
19	Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis PLoS ONE ·Shahinaz M. Gadalla, Ruth M. Pfeiffer, Sigurður Y. Kristinsson, Magnus Björkholm, James E. Hilbert, Richard T. Moxley, Ola Landgren, Mark H. Greene	2013	25
20	A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma Allergy and Asthma Proceedings ·David Miller, Chester C. Wood, Eric D. Bateman, Craig LaForce, Jon Blatchford, James E. Hilbert, Abhya Gupta, Andrew Fowler	2017	22

About James E. Hilbert

James E. Hilbert is a scholar working on Cellular and Molecular Neuroscience, Neurology, Immunology and Allergy, Rehabilitation and Molecular Biology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (20 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Mitochondrial Function and Pathology (6 papers), Muscle Physiology and Disorders (6 papers), DNA Repair Mechanisms (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers), Hereditary Neurological Disorders (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (674 citations), Neurology (363 citations), Rehabilitation (119 citations), Orthopedics and Sports Medicine (107 citations) and Molecular Biology (590 citations). James E. Hilbert has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Richard T. Moxley, Gary A. Sforzo, T. Swensen, Charles A. Thornton, William B. Martens, Elizabeth Luebbe, Michael McDermott, Mark H. Greene, Jean M. Bidlack and Wennan Xiong. Their work appears in journals such as Neurology, Muscle & Nerve, Journal of Neurology, Journal of Medicinal Chemistry and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact